<SEC-DOCUMENT>0001144204-19-018975.txt : 20190510
<SEC-HEADER>0001144204-19-018975.hdr.sgml : 20190510
<ACCEPTANCE-DATETIME>20190410070016
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-19-018975
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190410

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protalix BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001006281
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				650643773
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100
		BUSINESS PHONE:		972-4-988-9488

	MAIL ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHODONTIX INC
		DATE OF NAME CHANGE:	19980422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EMBASSY ACQUISITION CORP
		DATE OF NAME CHANGE:	19960124
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">April 10, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Joseph McCann</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Healthcare and Insurance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporate Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mail Stop 4720</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD><U>Protalix BioTherapeutics, Inc.</U><BR>
<U>Registration Statement on Form S-3</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><U>Filed March 29, 2019</U><BR>
<U>File No. 333-230604</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. McCann:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We refer to the registration statement on
Form S-3 (File No. 333-230604) (the &ldquo;Registration Statement&rdquo;) of Protalix BioTherapeutics, Inc., a Delaware corporation
(the &ldquo;Company&rdquo;). In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully
requests the acceleration of the effectiveness of the Registration Statement so that it may become effective at 4:05 p.m. (Eastern
time) on April 12, 2019 or as soon as practicable thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We thank you in advance for your time and attention to the Registration
Statement. Should you wish to discuss the enclosed materials at any time, please do not hesitate to contact me at +972 (4) 902-8100
or YossiM@protalix.com, or the Company&rsquo;s counsel, Anna T. Pinedo of Mayer Brown LLP at +1 (212) 506-2275 or apinedo@mayerbrown.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Yossi Maimon<BR>
<BR>
Yossi Maimon<BR>
Vice President and Chief Financial Officer<BR>
Protalix BioTherapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">cc:</TD><TD STYLE="text-align: justify">Moshe Manor</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Protalix BioTherapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0">Anna T. Pinedo<BR>
Mayer Brown LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-size: 8pt">2 Snunit Street,
Science Park P.O.B. 455, Carmiel 20100, Israel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-size: 8pt">Tel: 972-4-988-9488
| Fax: 972-4-988-9489 | Web: www.protalix.com</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X *8# 2(  A$! Q$!_\0
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MG!((0YQQ6XZ+(C(ZAD8$,K#((]#0!S_@[1M$TS1X[C1FDGCNU$C7,S;I9/\
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LT#3"5H8S*.CE!N_/\!^5/=%D4HZAE/4,,@T44 *H"J%4  #  '2BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
